Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Muir

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
Digestive Diseases and Sciences|March 19, 2011
The protease inhibitor era: an opportunity to improve the quality of careAndrew J Muir
Clinics in Liver Disease|May 1, 2012
Surgical clearance for the patient with chronic liver diseaseAndrew J Muir
The American Journal of Gastroenterology|April 16, 2014
The rapid evolution of treatment strategies for hepatitis CAndrew J Muir
Infectious Disease Clinics of North America|October 23, 2012
Approach to the treatment-naïve patient with HCV genotype 1 infectionAndrew J Muir
North Carolina Medical Journal|May 8, 2016
State of the State in GastroenterologyAndrew J Muir
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 3, 2020
What Clues Can We Use From Primary Sclerosing Cholangitis With Inflammatory Bowel Disease Phenotypes?Andrew J Muir
Clinical Therapeutics|July 20, 2015
Understanding the Complexities of CirrhosisAndrew J Muir
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2019
Is Magnetic Resonance Cholangiopancreatography Worth a Thousand Words in Determining Prognoses of Patients With Primary Sclerosing Cholangitis?Andrew J Muir
Expert Review of Anti-Infective Therapy|November 26, 2011
Telaprevir for the treatment of chronic hepatitis C infectionAndrew J Muir
Journal of Clinical Gastroenterology|January 19, 2013
IL28B in the era of direct-acting antivirals for hepatitis CAndrew J Muir
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
Digestive Diseases and Sciences|March 19, 2011
The protease inhibitor era: an opportunity to improve the quality of careAndrew J Muir
Clinics in Liver Disease|May 1, 2012
Surgical clearance for the patient with chronic liver diseaseAndrew J Muir
The American Journal of Gastroenterology|April 16, 2014
The rapid evolution of treatment strategies for hepatitis CAndrew J Muir
Infectious Disease Clinics of North America|October 23, 2012
Approach to the treatment-naïve patient with HCV genotype 1 infectionAndrew J Muir
North Carolina Medical Journal|May 8, 2016
State of the State in GastroenterologyAndrew J Muir
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 3, 2020
What Clues Can We Use From Primary Sclerosing Cholangitis With Inflammatory Bowel Disease Phenotypes?Andrew J Muir
Clinical Therapeutics|July 20, 2015
Understanding the Complexities of CirrhosisAndrew J Muir
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2019
Is Magnetic Resonance Cholangiopancreatography Worth a Thousand Words in Determining Prognoses of Patients With Primary Sclerosing Cholangitis?Andrew J Muir
Expert Review of Anti-Infective Therapy|November 26, 2011
Telaprevir for the treatment of chronic hepatitis C infectionAndrew J Muir
Journal of Clinical Gastroenterology|January 19, 2013
IL28B in the era of direct-acting antivirals for hepatitis CAndrew J Muir
Pageof 19